BARCLAYS PLC - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 81 filers reported holding CUE BIOPHARMA INC in Q4 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q2 2024$22
-62.7%
18,298
-41.7%
0.00%
Q1 2024$59
-59.6%
31,404
-43.4%
0.00%
Q4 2023$146
+421.4%
55,529
+362.2%
0.00%
Q3 2023$28
-41.7%
12,013
-7.2%
0.00%
Q2 2023$48
+118.2%
12,946
+114.7%
0.00%
Q1 2023$22
+29.4%
6,0290.0%0.00%
Q4 2022$17
-99.9%
6,029
-2.6%
0.00%
Q3 2022$14,000
-22.2%
6,188
-14.2%
0.00%
Q2 2022$18,000
-70.0%
7,214
-40.9%
0.00%
Q1 2022$60,000
-94.0%
12,211
-86.3%
0.00%
Q4 2021$1,006,000
+249.3%
88,842
+349.0%
0.00%
Q3 2021$288,000
+336.4%
19,785
+251.3%
0.00%
Q2 2021$66,000
-78.1%
5,632
-77.2%
0.00%
Q1 2021$302,000
+81.9%
24,730
+85.4%
0.00%
Q4 2020$166,000
-42.0%
13,342
-29.9%
0.00%
Q3 2020$286,000
-24.9%
19,028
+22.4%
0.00%
Q2 2020$381,000
+305.3%
15,547
+133.0%
0.00%
Q1 2020$94,000
-70.3%
6,672
-66.6%
0.00%
Q4 2019$317,000
+164.2%
19,957
+40.2%
0.00%
Q3 2019$120,000
+14.3%
14,235
+22.4%
0.00%
Q2 2019$105,000
+162.5%
11,632
+126.5%
0.00%
Q1 2019$40,000
-33.3%
5,136
-22.5%
0.00%
Q3 2018$60,000
+300.0%
6,628
+412.2%
0.00%
Q2 2018$15,000
-42.3%
1,294
-29.8%
0.00%
Q1 2018$26,0001,8430.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
Corriente Advisors, LLC 1,437,445$21,634,00010.97%
Prosight Management, LP 709,936$10,685,0005.08%
Voss Capital, LP 226,573$3,410,0001.94%
Robertson Stephens Wealth Management, LLC 484,000$7,284,0001.79%
Slate Path Capital LP 1,483,619$22,328,0001.27%
Nantahala Capital Management 2,342,216$35,250,0001.08%
SANDERS MORRIS HARRIS LLC 142,430$2,312,0000.63%
Rock Creek Group, LP 80,000$1,204,0000.62%
PRECEPT MANAGEMENT LLC 150,000$2,258,0000.55%
PA Capital LLC 46,850$705,0000.50%
View complete list of CUE BIOPHARMA INC shareholders